Abstract:Purpose Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the most frequently mutated human tumor suppressor genes. The present study aims to investigate the role of PTEN mutation in breast carcinogenesis by analyzing PTEN mutation spectrum and the protein expression in breast cancers, adjacent hyperplastic lesions, benign breast lesions and normal breast tissues. Methods All 9 exons of PTEN gene were amplified by PCR with DNA extracted from 50 of human breast cancers and corresponding adjacent breast hyperplasia tissues, adjacent normal breast tissues, as well as 50 breast benign lesions residing in or around Yunnan, China, respectively. PCR products were then sequenced for mutation screening. And we also proved the effect of mutations on the expression of PTEN protein by immunohistochemistry. Results PTEN mutations were detected in 11 of 50 (22%) breast cancers and 4 of 50 (8%) adjacent ductal hyperplasia, all of which were atypical ductal hyperplasia and same PTEN mutation were detected in the corresponding cancer tissues. No PTEN mutation was detected in all adjacent normal breast tissues and 50 cases of breast benign lesions. The mutation sites concentrated at exon 3, 4, 5 and 7; no mutation was detected in exon 1, 2, 6, 8, or 9 and splicing sites of all introns. The hottest mutation spots were exon 5 with missense mutations. Immunohistochemical analysis showed that 24 of 50 (48%) breast cancers and 6 of 50 (12%) adjacent breast hyperplasia demonstrated negative immuno-staining of PTEN (loss of PTEN protein expression). All the 4 adjacent breast tissues harbored PTEN mutations and 9 of 11 breast cancers with PTEN mutation were loss of PTEN expression. Statistical analysis revealed that PTEN gene mutations were correlated with the PTEN expression. Conclusions The incidence of PTEN mutations is relatively high in patients with sporadic breast cancer in the region of Yunnan, China and exists at the early stage of breast cancer development. The PTEN mutations have significant effect on the expression silencing of PTEN protein indicating the important role of PTEN mutation in carcinogenesis of breast cancers.

Pten／mmac1／tep1抑癌基因与子宫内膜癌的相关性

The Clinical Significance of PTEN Protein Expression in Colorectal Carcinoma

Mutations of PTEN Gene in 117 Chinese Patients with Malignant Melanoma and Their Clinical Significance

Apoptotic Effects of the Exogenous PTEN Tumor Suppressor Gene on Human Mucoepidermoid Carcinoma Cell Line

Heparanase mRNA expression and point mutation in hepatocellular carcinoma

Mutation Analysis of Novel Human Liver-Related Putative Tumor Suppressor Gene in Hepatocellular Carcinoma

Effect of stability of PTEN on hepatocellular carcinoma

P73、P51基因在乳腺癌组织中mRNA的表达及意义

The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review

A study on the mutation and expression of c-kit and PDGFR-α gene in gastrointestinal stromal tumor

Expression of PTEN Protein in Gastric Carcinoma, Adjacent Mucosa and Precancerous Lesions of Stomach and Its Significance

PTEN mutation spectrum in breast cancers and breast hyperplasia

EXPRESSION OF PTEN GENE IN HUMAN HEPATOCELLULAR CARCINOMA AND ITS CLINICAL SIGNIFICANCE

Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy

Decoding PTEN: from biological functions to signaling pathways in tumors

Epigenetic and Genetic Alterations of PTEN in Hepatocellular Carcinoma

Structural or functional defects of PTEN in urothelial cells lacking P53 drive basal/squamous-subtype muscle-invasive bladder cancer

Epigenetic Changes of Pituitary Tumor-Derived Transforming Gene 1 in Pancreatic Cancer.

Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.

Pten In Regulating Hematopoiesis And Leukemogenesis

The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets